Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0TN0A
|
||||
| Former ID |
DNC004658
|
||||
| Drug Name |
1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527671] | ||
| Formula |
C18H18N2O2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCCC(=O)C2=NC3=C(O2)C=CC=N3
|
||||
| InChI |
1S/C18H18N2O2/c21-15(18-20-17-16(22-18)12-7-13-19-17)11-6-2-5-10-14-8-3-1-4-9-14/h1,3-4,7-9,12-13H,2,5-6,10-11H2
|
||||
| InChIKey |
VPZHQLPAKFVGKX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [527671] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.